stockrow
Sunday 8 November 2026
Export SCLX’s income statement to Excel — free account
Scilex Holding Company
SCLXHealthcare Drug Manufacturers General
Scilex Holding Company’s revenue for fiscal 2025 (year ended December 2025) was $30.3 million, down 46.5% from fiscal 2024.
- Revenue
- −22.8%
- EPS
- −124.4%
- Free cash flow
- −203.8%
- Total debt
- +102.7%
Quarter to June 2026, against a year earlier
1.70
0.00
0.00%
Follow SCLX
Alert me
| Dec '17 | Jan '20 | Dec '20 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | 4 | 4 | 6 | 3 |
P/E ratio |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | — | (7.57) | 340.70 | (2.65) | (11.69) | (13.39) | (7.93) |
P/S ratio |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 15.07 | 3.40 | 5.26 | 3.57 |
Altman Z″-Score (non-manufacturers) |
— | — | (1,192.57) | (28.02) | (30.94) | (22.43) | (18.49) | (36.61) | (41.88) | (22.99) |
P/FCF ratio |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.42 | 29.57 |
Beneish M-Score |
— | — | — | — | (6.16) | — | (1.83) | (7.64) | (7.30) | (7.77) |
P/Operating CF |
— | — | (3,671,330.77) | (2,848,373.08) | (38.31) | (29.75) | (790.34) | (29.49) | 117.53 | (6.18) |
P/B ratio |
— | — | 255,226.20 | 198,015.24 | 0.00 | 0.00 | 15.81 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
— | — | 255,226.20 | 198,015.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 15.16 | 5.74 | 5.84 | 5.99 |
EV/EBITDA |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | 0.00 | 0.00 | (41.89) | (33.54) | (27.12) | (12.97) | 17.07 | 47.47 |
EV/FCF |
— | — | 0.00 | 0.00 | (41.89) | (33.54) | (27.11) | (12.95) | 17.10 | 49.59 |
Quick Ratio |
— | 0.17 | 0.17 | 0.11 | 0.11 | 0.52 | 0.52 | 0.15 | 0.11 | 0.05 |
Current Ratio |
— | 0.17 | 0.17 | 0.14 | 0.14 | 0.66 | 0.66 | 0.19 | 0.16 | 0.08 |
Net Debt/EBITDA |
— | (15.00) | 0.00 | (4.75) | (5.35) | 0.00 | 0.05 | (1.03) | (0.40) | (0.27) |
Debt/Assets |
0.00% | 62.66% | 0.00% | 198.57% | 171.29% | 0.00% | 0.00% | 107.03% | 37.52% | 22.81% |
Debt/Equity |
— | 6.68 | 0.00 | (0.69) | (0.60) | 0.00 | 0.00 | (0.63) | (0.18) | (0.39) |
Asset Turnover |
— | 0.00 | 118.10 | 0.00 | 0.80 | 0.00 | 0.46 | 0.50 | 0.58 | 0.13 |
Operating CF/Net income |
— | 0.21 | 0.66 | 0.32 | 0.32 | 0.91 | 0.91 | 0.12 | (0.27) | (0.01) |
Capex/Depreciation |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.01) | 0.00 | 0.00 |
Interest Coverage |
— | — | (2.69) | (65.50) | (3.05) | — | (5.27) | (98.72) | (42.48) | (30.20) |
| — | (33.69%) | (254,112.30%) | 0.00% | 79.00% | 0.00% | 24.90% | 244.29% | 39.83% | 199.06% | |
| — | (6.32%) | (23,819.05%) | 0.00% | (226.35%) | 0.00% | (28.41%) | (177.79%) | (74.96%) | (175.78%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (92.93%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | 4.19% | 31,616.10% | 61.27% | 60.73% | 175.26% | 161.55% | 82.30% | 33.49% | 93.23% |
Average Days of Receivables |
— | — | 0.00 | 166.29 | 166.29 | 203.80 | 203.80 | 270.16 | 170.55 | 183.92 |
Research and Development Expense of Revenue |
— | — | 42.28% | 29.38% | 29.38% | 23.81% | 23.81% | 27.27% | 17.04% | 68.46% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 182.39% | 161.39% | 161.52% | 170.52% | 170.62% | 255.95% | 210.31% | 882.17% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.67 | 0.67 | 0.62 | 0.62 | 0.49 | 0.49 | 0.38 |
Share Based Compensation of Revenue |
— | — | 22.90% | 0.00% | 18.59% | 0.00% | 13.88% | 31.23% | 27.72% | 51.21% |
Graham Net Nets |
— | — | 0.00 | 0.00 | (0.26) | (0.33) | (0.04) | (1.43) | (0.82) | (4.98) |
Graham Number |
— | — | 0.00 | 0.00 | 175.64 | 42.27 | 0.00 | 248.62 | 54.28 | 123.61 |
Earnings Yield |
— | — | 0.00% | 0.00% | (8.25%) | (10.63%) | (4.08%) | (76.91%) | (141.07%) | (361.42%) |
Free Cash Flow Yield |
— | — | 0.00% | 0.00% | (2.67%) | (3.44%) | (3.71%) | (13.05%) | 6.49% | 3.38% |
Revenue per Share |
— | 0.00 | 6.20 | 0.24 | 8.24 | 0.28 | 9.91 | 12.54 | 5.62 | 2.74 |
Operating CF per Share |
— | 0.00 | (8.28) | (0.22) | (7.54) | (0.16) | (5.54) | (5.56) | 1.92 | 0.35 |
Capex per Share |
— | 0.00 | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 | (0.01) | 0.00 | (0.01) |
Free Cash Flow per Share |
— | 0.00 | (8.28) | (0.22) | (7.54) | (0.16) | (5.54) | (5.56) | 1.92 | 0.33 |
Cash per Share |
— | 0.00 | 0.01 | 0.03 | 1.14 | 0.02 | 0.57 | 1.05 | 0.33 | 1.00 |
Shareholders Equity per Share |
— | 0.00 | 0.00 | (1.69) | (58.92) | 0.27 | 9.44 | (46.41) | (19.15) | (19.19) |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | 0.00 | (1.69) | (58.92) | 0.27 | 9.44 | (46.41) | (19.15) | (19.19) |
Free Cash Flow |
— | 0.00 | (31.49) | (28.66) | (28.66) | (21.26) | (21.26) | (20.74) | 19.35 | 3.68 |
Working Capital |
— | (0.15) | (0.15) | (146.42) | (146.42) | (15.23) | (15.23) | (203.60) | (218.09) | (445.29) |
Capital Expenditures |
— | — | (0.02) | — | — | (2.07) | (0.01) | (0.03) | — | (0.13) |
Net Current Asset Value |
— | (0.15) | (0.15) | (278.80) | (278.80) | (20.68) | (20.68) | (227.47) | (244.05) | (538.37) |
EV/EBIT |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
— | — | 0.00 | 1.97 | 14.52 | 2.34 | 9.20 | 5.83 | 6.16 | 5.76 |
Cash ROIC |
— | (0.75%) | (63,995.93%) | 44.24% | 33.31% | 0.00% | (55.34%) | 34.23% | (12.52%) | (3.13%) |
Accounts Receivable Turnover |
— | — | 0.00 | 0.00 | 2.19 | 0.00 | 2.14 | 1.67 | 1.85 | 1.45 |
Accounts Payable Turnover |
— | — | 18.01 | 0.00 | 0.30 | 0.00 | 0.67 | 0.63 | 0.36 | 0.15 |
Inventory Turnover |
— | — | 0.00 | 0.00 | 1.42 | 0.00 | 5.48 | 5.61 | 5.02 | 2.93 |
Average Days of Payables |
— | — | 5.10 | 210.93 | 2,399.72 | 208.99 | 285.66 | 953.27 | 1,150.84 | 2,970.76 |
Days of Inventory on Hand |
— | — | 0.00 | 126.15 | 257.33 | 34.08 | 46.58 | 98.09 | 53.28 | 164.92 |
Average Receivables |
— | — | — | — | 14.27 | 17.75 | 17.75 | 27.92 | 30.52 | 20.84 |
Average Payables |
— | — | 0.12 | 2.16 | 11.96 | 16.17 | 16.17 | 24.70 | 46.79 | 69.44 |
Average Inventory |
— | — | — | — | 2.56 | 1.97 | 1.97 | 2.80 | 3.33 | 3.61 |
Average Assets |
— | 0.10 | 0.20 | 39.07 | 39.07 | 82.23 | 82.23 | 93.92 | 97.13 | 228.97 |
Average Common Equity |
— | 0.02 | 0.02 | (111.93) | (111.93) | (93.82) | (93.82) | (68.35) | (182.79) | (202.20) |
Columns are period end dates · fundamentals updated 26 Oct 2026